Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Human papillomavirus (HPV) type 52 is a high-risk HPV responsible for cervical cancer. HPV type 52 is common around the world and is the most common in some Asian regions. The available prophylactic HPV vaccines protect only from HPV types 16 and 18. Supplementing economical vaccines that target HPV type 52 may satisfactorily complement available prophylactic vaccines. A codon-adapted HPV 52 L1 gene was expressed in the methylotrophic yeast Hansenula polymorpha, which is used as an industrial platform for economical hepatitis B surface antigen particle production in China. We found that the recombinant proteins produced in this expression system could form virus-like particles (VLPs) with diameters of approximately 50 nm. This study suggests that the HPV 52 VLPs produced in this platform may satisfactorily complement available prophylactic vaccines in fighting against HPVs prevalent in Asia.
Abstract
Human papillomavirus (HPV) type 52 is a high-risk HPV responsible for cervical cancer. HPV type 52 is common around the world and is the most common in some Asian regions. The available prophylactic HPV vaccines protect only from HPV types 16 and 18. Supplementing economical vaccines that target HPV type 52 may satisfactorily complement available prophylactic vaccines. A codon-adapted HPV 52 L1 gene was expressed in the methylotrophic yeast Hansenula polymorpha, which is used as an industrial platform for economical hepatitis B surface antigen particle production in China. We found that the recombinant proteins produced in this expression system could form virus-like particles (VLPs) with diameters of approximately 50 nm. This study suggests that the HPV 52 VLPs produced in this platform may satisfactorily complement available prophylactic vaccines in fighting against HPVs prevalent in Asia.
참고문헌 (23)
- Bian G, "Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HSsAg) induces potent HBsAg-specific Th1 and Th2 immune responses", Vaccine, 28, pp.187~194 (2009)
- Bruni L, "Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings", J. Infect. Dis, 202, pp.1789~1799 (2010)
- Chen Q, "Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China", PLoS One, 7, pp.e32149~ (2012)
- Chui SH, "Human papillomavirus infection in Macau women", Public Health, 126, pp.600~604 (2012)
- Deschuyteneer M, "Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in CervarixTM, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine", Hum. Vaccine, 6, pp.407~419 (2010)
- D iminsky D, "Comparison between hepatitis B surface antigen (HBsAg)particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity", Vaccine, 15, pp.637~647 (1997)
- Faber KN, "Highly-efficient electrotransformation of the yeast Hansenula polymorpha", Curr. Genet, 25, pp.305~310 (1994)
- Garland SM, "Human papillomavirus vaccines:current status and future prospects", Drugs, 70, pp.1079~1098 (2010)
- Hanumantha Rao N, "Expression o f codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles", Vaccine, 29, pp.7326~7334 (2011)
- Hoang HT, "Infection with high-risk HPV types among female sex workers in northern Vietnam", J. Med. Virol, 85, pp.288~294 (2013)
- Kim HJ, "Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae", Biotechnol. Lett, 35, pp.413~421 (2013)
- K irnbauer R, "Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic", Proc. Natl. Acad. Sci. USA, 89, pp.12180~12184 (1992)
- 이은희, "Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay", Journal of Korean Medical Science, 27(9), pp.1091~1097 (2012), 대한의학회
- Li HM, "Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: implications for interventions", J. Med. Virol, 84, pp.798~803 (2012)
- Lin H, "High prevalence of genital papillomavirus type 52 and 58 in women attending gynecologic practitioners in south Taiwan", Gynecol. Oncol, 101, pp.40~45 (2006)
- Liu C, "Diverse expression levels of two codon-optimized genes that encode human papillomavirus type 16 major protein L1 in Hansenula polymorpha", Biotechnol. Lett, 36, pp.937~945 (2014)
- Mbaye el HS, "Human papillomavirus infection in women in four regions of Senegal", J. Med. Virol, 86, pp.248~256 (2014)
- Quek SC, "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia", Int. J. Gynycol. Cancer, 23, pp.148~156 (2013)
- Smi th JS, "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update", Int. J. Cancer, 121, pp.621~632 (2007)
- Si monella LM, "Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand", BMC Infect. Dis, 13, pp.114~ (2013)
- Takehara K, "Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women", Patholog. Res. Int, pp.246936~ (2011)
- Zhao FH, "Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial", Int. J. Cancer, 135, pp.2604~2611 (2014)
- Zhao Q, "Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16virus-like particles", Nanomedicine, 8, pp.1182~1189 (2012)